| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 08/07/2003 | US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 08/06/2003 | EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/06/2003 | CN1434821A Quinazoline derivatives for the treatment of tumours |
| 08/06/2003 | CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 08/06/2003 | CN1434717A Medicine for treating obesity and method of producing and use thereof |
| 08/05/2003 | US6602866 Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 08/05/2003 | US6602525 Compositions comprising nitrofurantoin and uva ursi |
| 07/31/2003 | WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 07/31/2003 | WO2003061652A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | US20030144305 Novel compounds |
| 07/31/2003 | CA2474269A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 07/31/2003 | CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 07/30/2003 | EP1330249A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/30/2003 | CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/29/2003 | US6600047 Substantially free from amlodipine aspartate side products, by reacting amlodipine or an acid addition salt thereof with excess maleic acid under acidic environment |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/23/2003 | CN1432010A 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs |
| 07/23/2003 | CN1431901A S-methyl-dihydro-zipprasidone for treatment of psychiatric and ocular disorders |
| 07/23/2003 | CN1115165C Externally applied medicated wine for treating traumatic injury and rheumatism |
| 07/22/2003 | US6596737 C10 carbamoyloxy substituted taxanes |
| 07/22/2003 | US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides |
| 07/17/2003 | US20030134878 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 07/17/2003 | US20030134844 Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome |
| 07/16/2003 | EP1327446A1 Controlled release oxycodone compositions |
| 07/16/2003 | EP1327445A1 Controlled release oxycodone compositions |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326633A1 Composition comprising immunogenic microparticles |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | CN1430515A Divided dose therapies with vascular damaging activity |
| 07/15/2003 | US6593330 Compounds and their use |
| 07/10/2003 | US20030130338 Method of treatment |
| 07/10/2003 | US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 07/10/2003 | US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents |
| 07/09/2003 | EP1325746A1 Controlled release oxycodone compositions |
| 07/09/2003 | CN1429225A C10 carbonate substituted taxanes as antitumor agents |
| 07/03/2003 | WO2003053942A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 07/03/2003 | WO2003053920A1 Crystals of bicalutamide and process for their production |
| 07/03/2003 | US20030125387 Antioestrogens, capable of eliciting complete ablation of the trophic effects of oestrogens; cancer therapy |
| 07/03/2003 | CA2467118A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 07/02/2003 | EP1175429B1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1426806A Health care food capable of eliminating honeycomb fat |
| 07/02/2003 | CN1426804A Health care food for reducing body weight due to excess fat in meal |
| 07/02/2003 | CN1426702A Health care food for maintaining intestinal health and assisting to reduce abdomen fat |
| 07/02/2003 | CN1112927C Pharmaceutical composition of corpus albicans emulsifier type lipophilic compound |
| 06/26/2003 | WO2003051851A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 06/26/2003 | WO2003051354A1 Method of treatment |
| 06/26/2003 | US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 06/26/2003 | US20030118644 A solid forms comprising low molecular weight peptide-based thrombin inhibitor having pH dependent solubility, cellulose or starch as disintegrant fillers; immediate release |
| 06/26/2003 | CA2469786A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 06/25/2003 | EP1320540A2 Peptidomimetic protease inhibitors |
| 06/25/2003 | CN1426423A Humanized antibodies that sequester amyloid beta peptide |
| 06/25/2003 | CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
| 06/25/2003 | CN1426407A N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
| 06/19/2003 | US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 06/19/2003 | US20030114527 Administering an immediate release tablets containing 400 mg of 5-methyl-2-(2'- chloro-6'-fluoroanilino)phenylacetic acid or salts to a patient for the treatment of cyclooxygenase-2 mediated diseases |
| 06/19/2003 | US20030114493 Antitumor agents |
| 06/19/2003 | US20030114443 Viricides, Aids therapy |
| 06/18/2003 | EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 06/18/2003 | EP1318835A1 Use of imidazoquinolinamines as adjuvants in dna vaccination |
| 06/18/2003 | CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/17/2003 | US6579982 Treating inflammation, cancer |
| 06/12/2003 | WO2003047580A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 06/12/2003 | US20030109551 A therapeutic or preventive agent for pulmonary insufficiency, containing as an active ingredient a diaminotrifluoromethylpyridine derivative represented by the formula (I) or its salt: anti-inflammatory agent or an anti- |
| 06/12/2003 | US20030109530 Diabetes, insulin resistance, dyslipidemia, obesity, high blood pressure, atherosclerosis, retinopathies and neurodegenerative disorders; synthesis by reacting a biguanide with an aldehyde, semiacetal or acetal in presence of acid catalyst |
| 06/12/2003 | US20030109509 Methods for treating dry eye |
| 06/12/2003 | CA2468044A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 06/11/2003 | EP1317280A2 Vaccine against streptococcus pneumoniae |
| 06/11/2003 | EP1317279A2 Vaccine against streptococcus pneumoniae |
| 06/10/2003 | US6576793 β2-adrenergic receptor agonists |
| 06/10/2003 | US6576648 Compound with growth hormone releasing properties |
| 06/10/2003 | CA2350195C Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| 06/05/2003 | WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 06/05/2003 | WO2003045392A2 Use of n-(indolcarbonyl-)piperazine derivatives |
| 06/05/2003 | WO2003045371A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists |
| 06/05/2003 | US20030105090 For therapy of cancer, diabetes |
| 06/05/2003 | US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema |
| 06/05/2003 | US20030104980 Treating sexual desire disorders with flibanserin |
| 06/05/2003 | US20030104081 Composition for treating obesity and esthetic treatment process |
| 06/05/2003 | CA2468494A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists |
| 06/05/2003 | CA2468380A1 Use of n-(indolecarbonyl)piperazine derivatives |
| 06/04/2003 | CN1422162A Composition and method for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 06/04/2003 | CN1422157A Divided dose therapies with vascular damaging activity |
| 05/30/2003 | WO2003043985A1 Heterocyclic compounds and methods of use |
| 05/29/2003 | US20030100518 13-Methyl erythromycin derivatives |
| 05/29/2003 | US20030100504 Treatment and diagnosis of insulin-resistant states |
| 05/29/2003 | US20030100500 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier |
| 05/29/2003 | US20030099704 Controlled release oxycodone compositions |
| 05/28/2003 | EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 05/28/2003 | EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine |
| 05/28/2003 | CN1420878A Compound with growth hormone releasing properties |
| 05/27/2003 | US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 05/22/2003 | WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003041724A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 05/22/2003 | WO2003041722A1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 05/22/2003 | CA2465776A1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 05/22/2003 | CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/21/2003 | EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |